October 06, 2025

What Links TBI and ALS Risk?

Researchers found a time-dependent link between traumatic brain injury and amyotrophic lateral sclerosis, with the highest risk in the 2 years after injury.

Conexiant

September 26, 2025

FDA Approves First Once-Daily Oral Therapy for Acromegaly

Once-daily paltusotine offers an oral alternative to monthly injections for eligible adults.

Conexiant

September 08, 2025

FDA Expands Indications for Von Willebrand Disease

FDA expands Vonvendi to adult routine prophylaxis (types 1 and 2) and pediatric on-demand/perioperative use.

Conexiant

September 04, 2025

Cisplatin-Free Toripalimab Tested for Head and Neck Cancer

Researchers note reduced rates of vomiting, fatigue, anemia, and leukopenia compared with standard therapy.

Conexiant

May 28, 2025

Kennedy Proposes NIH Publishing Ban

"We're probably going to stop publishing in The Lancet, New England Journal of Medicine, JAMA, and those other journals because they're all corrupt."

Conexiant

August 27, 2025

Drug for Dizziness May Increase Falls

Researchers find elevated risk across adult age groups, not just in older adults.

Conexiant

August 27, 2025

SCC: One Tonsil or Two?

Overall and disease-free survival remain stable in patients undergoing unilateral tonsil surgery compared with bilateral procedures.

Conexiant

September 03, 2025

Study Maps Delta-Like Protein 3 and SEZ6 Across Tumor Types

Researchers highlight distinct Delta-like protein 3 and seizure-related 6 homolog patterns in neuroendocrine tumors.

Conexiant

August 28, 2025

CD68/CD163 Mark Worse Outcomes in Skeletal Hodgkin Lymphoma, Study

Skeletal classic Hodgkin lymphoma shows a macrophage-rich, B-cell–poor microenvironment, with high CD68/CD163 linked to worse survival.

Conexiant